Last reviewed · How we verify
Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma] — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma] (Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma]) — Medical University of Warsaw.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma] TARGET | Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma] | Medical University of Warsaw | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma] CI watch — RSS
- Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma] CI watch — Atom
- Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma] CI watch — JSON
- Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma] alone — RSS
Cite this brief
Drug Landscape (2026). Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma] — Competitive Intelligence Brief. https://druglandscape.com/ci/magnesium-sulphate-inj-magnesii-sulfurici-polpharma. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab